6-32028766-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001002029.4(C4B):c.3304G>A(p.Glu1102Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,563,262 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002029.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C4B | NM_001002029.4 | c.3304G>A | p.Glu1102Lys | missense_variant | 26/41 | ENST00000435363.7 | NP_001002029.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C4B | ENST00000435363.7 | c.3304G>A | p.Glu1102Lys | missense_variant | 26/41 | 1 | NM_001002029.4 | ENSP00000415941.2 | ||
C4B | ENST00000425700.3 | c.3304G>A | p.Glu1102Lys | missense_variant | 26/40 | 1 | ENSP00000391933.2 | |||
C4B | ENST00000647698.1 | c.2008G>A | p.Glu670Lys | missense_variant | 16/31 | ENSP00000497270.1 | ||||
C4B | ENST00000648821.1 | n.1917G>A | non_coding_transcript_exon_variant | 13/27 |
Frequencies
GnomAD3 genomes AF: 0.000666 AC: 94AN: 141074Hom.: 5 Cov.: 22
GnomAD3 exomes AF: 0.000187 AC: 45AN: 240246Hom.: 5 AF XY: 0.000107 AC XY: 14AN XY: 130316
GnomAD4 exome AF: 0.0000598 AC: 85AN: 1422072Hom.: 10 Cov.: 33 AF XY: 0.0000424 AC XY: 30AN XY: 707730
GnomAD4 genome AF: 0.000666 AC: 94AN: 141190Hom.: 5 Cov.: 22 AF XY: 0.000658 AC XY: 45AN XY: 68358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.3304G>A (p.E1102K) alteration is located in exon 26 (coding exon 26) of the C4B gene. This alteration results from a G to A substitution at nucleotide position 3304, causing the glutamic acid (E) at amino acid position 1102 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at